No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
PNFP Pinnacle Financial Partners
- 94.670
- +1.580+1.70%
Close Jul 22 16:00 ET
- 94.670
- 0.0000.00%
Post 16:22 ET
7.31BMarket Cap18.75P/E (TTM)
95.130High91.050Low493.19KVolume92.750Open93.090Pre Close46.38MTurnover0.65%Turnover Ratio13.26P/E (Static)77.20MShares97.49052wk High1.23P/B7.18BFloat Cap59.13652wk Low0.88Dividend TTM75.85MShs Float108.053Historical High0.93%Div YieldTTM4.38%Amplitude1.783Historical Low94.037Avg Price1Lot Size
Post-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Pinnacle Is One of the Country's Top 10 Workplaces for Millennials
Firm earned the No. 9 spot nationwide in FORTUNE magazine list Pinnacle Financial Partners (Nasdaq/NGS: PNFP) remains one of the best workplaces in the nation for millennials. The firm earned the No. 9 spot on the
Janney Montgomery Initiates Pinnacle Financial Partners(PNFP.US) With Buy Rating
Janney Montgomery analyst Brian Martin initiates coverage on $Pinnacle Financial Partners(PNFP.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 84.6% and a total
Janney Montgomery Sticks to Their Buy Rating for Pinnacle Financial Partners (PNFP)
Pinnacle Financial Partners (NASDAQ:PNFP) Has Announced A Dividend Of $0.22
Express News | Pinnacle Financial Partners Inc : UBS Raises Target Price to $97 From $86
Pinnacle Financial Price Target Raised to $113.00/Share From $93.00 by Citigroup
Pinnacle Financial Price Target Raised to $113.00/Share From $93.00 by
Comments
The insider selling at around the current share price of US$80.90 is a cause for slight concern. The lack of insider purchases in the last year, despite significant insider ownership, does not inspire confidence in the company.
Have Pinnacle Financial Partners Insiders Been Selling Stock?Efficient markets hypothesis implies markets are over-reactive and investors may not always be rational. The firm's higher EPS growth versus its annual share price increment indicates a potential surge in market caution towards the stock.
Insider trading at Pinnacle Financial Partners suggests a bearish signal as there's been more selling than buying in the past year. While strong insider ownership is seen as positive, extensive share selling warrants closer inspection.
Upgrades
• $Allegiance(ABTX.US$ : Raymond James Upgrades to Outperform from Market Perform - PT $43
• $Bunge(BG.US$: JPMorgan Upgrades to Overweight from Neutral - PT $106 (from $130)
• $Cerence(CRNC.US$ : RBC Capital Upgrades to Sector Perform from Underperform - PT $27 (from $28)
• $First Mid Bancshares(FMBH.US$ : Raymond James Upgrades to Outperform from Market Perform - PT $45
• $Lamar Advertising Co(LAMR.US$ : Citigroup Up...
• $Allegiance(ABTX.US$ : Raymond James Upgrades to Outperform from Market Perform - PT $43
• $Bunge(BG.US$: JPMorgan Upgrades to Overweight from Neutral - PT $106 (from $130)
• $Cerence(CRNC.US$ : RBC Capital Upgrades to Sector Perform from Underperform - PT $27 (from $28)
• $First Mid Bancshares(FMBH.US$ : Raymond James Upgrades to Outperform from Market Perform - PT $45
• $Lamar Advertising Co(LAMR.US$ : Citigroup Up...
11
Gainers:
• $Checkmate Pharmaceuticals(CMPI.US$ +331.5% (Regeneron Pharma (REGN) to acquire CMPI for $10.50/share in cash)
• $Axsome Therapeutics(AXSM.US$ +27.9% (received and agreed to Postmarketing Requirements/Commitments proposed by the FDA with respect to the New Drug Application for its AXS-05 product candidate for the treatment of major depressive disorder)
• $Super Micro Computer(SMCI.US$ +14.3% (earnings report)
• $Plug Power(PLUG.US$ +9.24% (t...
• $Checkmate Pharmaceuticals(CMPI.US$ +331.5% (Regeneron Pharma (REGN) to acquire CMPI for $10.50/share in cash)
• $Axsome Therapeutics(AXSM.US$ +27.9% (received and agreed to Postmarketing Requirements/Commitments proposed by the FDA with respect to the New Drug Application for its AXS-05 product candidate for the treatment of major depressive disorder)
• $Super Micro Computer(SMCI.US$ +14.3% (earnings report)
• $Plug Power(PLUG.US$ +9.24% (t...
16
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg